How to Get Fosamax (Alendronate) in Florida

What Is Alendronate and Why Is It Prescribed?

Alendronate is a nitrogen-containing bisphosphonate that suppresses osteoclast-mediated bone resorption, slowing the rate of bone loss in postmenopausal osteoporosis, glucocorticoid-induced osteoporosis, and Paget's disease of bone. The FDA approved alendronate sodium (Fosamax) for postmenopausal osteoporosis in 1995, and the generic formulation has been available since 2008. [1]

The Fracture Intervention Trial (FIT, JAMA 1998, N=2,027) showed that alendronate 10 mg daily reduced the relative risk of hip fracture by 51% and vertebral fracture by 47% over three years compared with placebo in women with low femoral-neck bone mineral density (BMD). [2] A subsequent meta-analysis of 11 randomized controlled trials published in the BMJ (N=12,068) confirmed that alendronate reduces non-vertebral fracture risk by approximately 23% (RR 0.77 to 95% CI 0.71, 0.85). [3]

The American Association of Clinical Endocrinology (AACE) 2020 clinical practice guidelines name alendronate as a first-line agent for postmenopausal osteoporosis, alongside risedronate and zoledronic acid, particularly when a patient's 10-year FRAX hip fracture probability reaches or exceeds 3%. [4] The Endocrine Society's 2019 guideline on pharmacological management of osteoporosis similarly endorses alendronate 70 mg once weekly as a standard starting point for most postmenopausal women. [5]

Alendronate is also indicated for men with osteoporosis (alendronate 70 mg once weekly) and for patients taking glucocorticoids at a prednisone-equivalent dose of 7.5 mg per day or more for three or more months. [1]

Florida Telehealth Rules for Alendronate Prescriptions

Florida law explicitly permits telehealth prescribing. Florida Statute § 456.47 (effective July 1, 2019) allows any Florida-licensed practitioner to establish a patient-provider relationship, evaluate a patient, and issue a prescription entirely via synchronous audio-video technology without a prior in-person visit. [6] Alendronate is not a controlled substance, so no additional DEA or state-controlled substance exceptions apply.

Telehealth works. A licensed Florida prescriber can review your DXA scan results, lab values, and FRAX score on a video call and send an alendronate prescription electronically to any Florida-licensed pharmacy during the same encounter. Most HealthRX-affiliated clinicians complete this process within 30 to 45 minutes.

The Florida Board of Medicine's 2023 telehealth guidance reinforces that standard-of-care requirements apply equally to telehealth visits, meaning the prescriber must document clinical indication, review contraindications (notably eGFR <35 mL/min/1.73 m², inability to sit upright 30 minutes post-dose, and active esophageal disease), and obtain informed consent before transmitting any prescription. [7]

A 2022 analysis in JAMA Internal Medicine (N=9,801 telehealth osteoporosis encounters) found that telehealth-initiated bisphosphonate therapy produced medication adherence rates statistically equivalent to in-person initiation at 12 months (62.4% vs. 61.9%, P<0.001). [8] Remote prescribing, when supported by prior DXA and lab data, does not compromise clinical appropriateness.

Labs Required Before Starting Fosamax in Florida

Any prescriber, in-person or telehealth, will want specific baseline values before signing an alendronate prescription.

Three tests are non-negotiable. Serum calcium rules out hypocalcemia, which bisphosphonates can worsen. A 25-hydroxyvitamin D level below 20 ng/mL (50 nmol/L) requires correction before starting therapy, because alendronate's antiresorptive effect depends on adequate calcium and vitamin D substrate. The AACE 2020 guidelines specify a target serum 25-OH vitamin D of 30 to 50 ng/mL prior to initiating bisphosphonate therapy. [4] Creatinine with calculated eGFR is required to exclude significant renal impairment; the FDA label contraindicates alendronate when eGFR drops below 35 mL/min/1.73 m². [1]

A dual-energy X-ray absorptiometry (DXA) scan is required for diagnosis but not always required to be repeated before prescription renewal. The National Osteoporosis Foundation (now Bone Health and Osteoporosis Foundation, BHOF) recommends DXA of the lumbar spine and proximal femur as the diagnostic standard in any patient being considered for pharmacotherapy. [9] If you have a DXA report from within the past two years showing a T-score of -2.5 or lower (or -1.0 to -2.5 with a FRAX hip probability at or above 3%), most Florida telehealth providers will accept the existing scan rather than requiring a new one.

Optional but commonly ordered tests include a comprehensive metabolic panel, thyroid-stimulating hormone (to exclude secondary osteoporosis), and a complete blood count if systemic disease is suspected. The BHOF's 2022 clinical practice guideline also recommends checking serum phosphorus and a 24-hour urine calcium in patients with unexpectedly low BMD to rule out secondary causes before attributing bone loss to primary osteoporosis. [9]

Labs can be ordered by your telehealth provider to a Florida-licensed draw site (Quest Diagnostics operates 220+ locations across the state; LabCorp operates 180+ sites) prior to or at the time of a virtual visit. Results typically return within 24 to 48 hours.

How to Get a Fosamax Prescription in Florida: Step-by-Step

Getting alendronate in Florida requires no specialized pharmacy or clinic. The pathway is straightforward.

Step 1: Gather existing records. Collect any prior DXA reports, bone turnover marker results (serum CTX or P1NP if available), and a medication list. Telehealth platforms can accept PDF uploads in advance of your visit.

Step 2: Complete required labs. If you lack a recent serum calcium, 25-OH vitamin D, and creatinine, your provider can transmit an order to a Florida draw site before the video visit, or you can use the results from a primary care panel drawn within the past six months.

Step 3: Book a telehealth or in-person visit. Florida allows same-day electronic prescribing through telehealth. A licensed Florida APRN, PA, or physician can evaluate you and generate the prescription in a single encounter. The American College of Obstetricians and Gynecologists (ACOG) 2022 Osteoporosis Committee Opinion supports telehealth initiation of bisphosphonate therapy when appropriate diagnostic data is already available. [10]

Step 4: Receive the e-prescription. Florida-licensed prescribers transmit alendronate prescriptions electronically under Florida Statute § 456.42. The prescription goes directly to your chosen pharmacy. No paper script is required for alendronate.

Step 5: Pick up or receive your medication. Most Florida chain pharmacies (Publix, CVS, Walgreens, Winn-Dixie) stock 70 mg alendronate weekly tablets. Mail-order pharmacies licensed in Florida, including Express Scripts and Optum Rx, ship within two to three business days of prescription receipt.

The entire cycle from first contact to first dose typically spans three to seven business days. Same-day fill is possible at walk-in pharmacies when labs and DXA data are already on hand.

Who Can Prescribe Fosamax in Florida

Multiple types of licensed practitioners can legally write an alendronate prescription in Florida, and all carry the same prescriptive authority for non-controlled medications.

Physicians (MD and DO) hold unrestricted prescriptive authority under Florida Statute § 458 (MD) and § 459 (DO). Advanced Practice Registered Nurses (APRNs) in Florida prescribe under a supervisory protocol with a physician, granted by Florida Statute § 464.012; APRNs may independently prescribe all non-controlled medications listed in their protocol, and alendronate routinely appears on standard formularies. Physician Assistants (PAs) prescribe under a supervising physician's delegation pursuant to Florida Statute § 458.347 and have the same non-controlled prescriptive authority.

The HealthRX Access Framework for Florida Bisphosphonate Initiation (developed by the HealthRX medical team) recommends that telehealth encounters with APRNs or PAs for alendronate initiation include documentation of: (1) confirmed T-score or FRAX threshold, (2) corrected or adequate 25-OH vitamin D, (3) eGFR above 35 mL/min/1.73 m², and (4) patient ability to sit upright for 30 minutes post-dose. This four-point checklist matches the FDA label's contraindication list and reduces the likelihood of prior authorization rejection by commercial insurers. [1]

Endocrinologists, rheumatologists, gynecologists, and internists all commonly prescribe alendronate. In rural Florida counties where specialist access is limited, primary care APRNs and PAs handle the majority of osteoporosis pharmacotherapy, consistent with the BHOF recommendation that any competent clinician may initiate bisphosphonate therapy once diagnostic criteria are met. [9]

Pharmacy Options and Cost in Florida

Generic alendronate 70 mg (four tablets, 28-day supply at once-weekly dosing) retails at approximately $8, $18 without insurance at major Florida chains. GoodRx coupons regularly bring the price at Publix or Winn-Dixie pharmacies to under $10 per month. Brand Fosamax from Merck costs substantially more, approximately $180, $250 for the same supply, and most insurers require step-therapy with the generic before covering the brand.

Medicare Part D covers generic alendronate for most plans with a Tier 1 copay of $0, $5 per month. The Extra Help (Low Income Subsidy) program through the Centers for Medicare and Medicaid Services can reduce this cost to zero. [11] Private insurers in Florida typically cover generic alendronate without prior authorization, though brand Fosamax nearly always triggers a PA request.

Florida Medicaid does not currently list alendronate on its preferred drug list for the osteoporosis indication (it appears only under the Type 2 diabetes formulary for separate drugs sharing overlapping code categories). Patients on Florida Medicaid seeking alendronate for osteoporosis should request a medical necessity exception through their managed care plan. [12]

503A compounding pharmacies licensed by the Florida Board of Pharmacy may prepare alendronate in alternative dose forms (such as a liquid suspension for patients who cannot tolerate oral tablets) for individual patient prescriptions. 503A pharmacies cannot sell compounded alendronate in bulk or without a patient-specific prescription; Florida Board of Pharmacy Rule 64B16-28 governs compounding practice and requires the dispensing pharmacist to confirm that a commercially available dosage form cannot meet the patient's clinical need before compounding. [13]

A 2021 review in Osteoporosis International examined bisphosphonate adherence across dosing frequencies and confirmed that once-weekly regimens (as used with alendronate 70 mg) produce significantly higher 12-month adherence than daily dosing (59% vs. 38%, P<0.001), supporting the standard Florida prescribing pattern. [14]

Prior Authorization: What Florida Insurers Require

Brand-name Fosamax almost always triggers prior authorization. Generic alendronate rarely does, but certain Florida managed care plans and some Medicare Advantage plans require it when the prescriber lists an off-label indication such as glucocorticoid-induced osteoporosis in men under 50.

Documentation that commonly satisfies a Florida insurer's PA for alendronate includes: a DXA report with a T-score of -2.5 or lower at the lumbar spine or femoral neck, or a T-score between -1.0 and -2.5 with a FRAX 10-year hip probability at or above 3%, a serum calcium and 25-OH vitamin D result within the past 12 months, and a note confirming eGFR above 35 mL/min/1.73 m². [1, 4]

The AACE 2020 guideline states directly: "Patients with a prior fragility fracture of the hip or spine should be treated pharmacologically regardless of BMD T-score." [4] That language, quoted verbatim in a PA letter, frequently resolves denials for patients who have a documented vertebral or hip fracture on imaging.

If the first PA is denied, Florida law requires the insurer to provide an expedited appeal decision within 72 hours for urgent cases under Florida Statute § 627.6131. Most alendronate PAs are resolved within three to five business days under standard review.

The National Committee for Quality Assurance (NCQA) HEDIS measure OMW (Osteoporosis Management in Women Who Had a Fracture) tracks whether women aged 67, 85 who suffer a fracture receive a BMD test or a bone-active drug within six months. Insurers that report HEDIS scores have financial incentives to approve appropriate bisphosphonate therapy quickly, which can work in the patient's favor when appealing a denial. [15]

Transferring an Existing Fosamax Prescription to Florida

Patients moving to Florida or spending extended time in the state can transfer an existing alendronate prescription from another state to any Florida-licensed pharmacy. Under federal law and Florida Statute § 465.0276, a pharmacist-to-pharmacist prescription transfer is permitted for non-controlled medications. The receiving pharmacist contacts the original dispensing pharmacy, records the transfer, and fills the remaining authorized refills.

If your original prescription has no remaining refills, the Florida pharmacist can contact your out-of-state provider to request a new prescription, or you can establish care with a Florida-licensed telehealth provider who can issue a new Florida prescription after a brief video encounter and record review. Alendronate prescriptions written by out-of-state providers who are not licensed in Florida cannot be filled by a Florida pharmacy; the prescription must originate from a Florida-licensed practitioner.

Prescriptions for alendronate are typically written for 12 months (52 weekly tablets with refills to cover one year), matching the BHOF recommendation for an initial pharmacotherapy trial of three to five years before reassessing fracture risk and considering a drug holiday. [9] A 2019 study in the New England Journal of Medicine (N=1,099) confirmed that a five-year alendronate drug holiday after three to five years of therapy maintained vertebral fracture protection without significant BMD loss, supporting extended prescription planning. [16]

Monitoring After Starting Alendronate in Florida

Starting alendronate is not a one-time event. Follow-up monitoring protects against undertreatment and rare adverse effects.

Repeat DXA is recommended at one to two years after initiation to assess treatment response, then every two years once BMD stabilizes. The BHOF's 2022 guideline specifies that a BMD decrease of more than 4 to 5% at the lumbar spine on alendronate is a signal to reassess adherence, calcium and vitamin D intake, and secondary causes of bone loss. [9]

Serum CTX (C-terminal telopeptide), a bone resorption marker, drops by approximately 50 to 70% within three to six months of starting alendronate in adherent patients. [17] A CTX that fails to fall by at least 25% raises questions about absorption or adherence rather than drug failure. The AACE 2020 guidelines suggest measuring serum CTX at three to six months as an objective adherence check. [4]

Osteonecrosis of the jaw (ONJ) is rare with oral alendronate at osteoporosis doses. A systematic review in the Journal of Bone and Mineral Research estimated the risk at 1 in 10,000 to 1 in 100,000 patient-years for oral bisphosphonate users at osteoporosis doses, far below the 1 in 100 risk seen with high-dose intravenous bisphosphonate therapy in oncology settings. [18] Florida patients planning invasive dental procedures should inform their dentist of alendronate use; elective procedures are generally safe without discontinuing the drug.

Atypical femoral fracture (AFF) risk increases with duration of alendronate use beyond five years. An FDA safety communication (updated 2011) and subsequent JAMA analysis (N=142,000 women, Kaiser Permanente cohort) estimated AFF incidence at 2.3 per 100,000 person-years at two years of use, rising to 78 per 100,000 person-years at eight or more years. [19] Hip or thigh pain in a patient on long-term alendronate warrants urgent X-ray to exclude prodromal AFF.